biomedicine

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder

Novel Nasal-Spray Nano-Formulation Enables Nose-To-Brain Delivery of Biodegradable Nanoparticles that can Encapsulate Psychedelic Substances such as Psilocybin Madrigal Mental Care, a biopharmaceutical company developing a breakthrough delivery system for psychedelic drugs, introduced its novel nanotechnology for the treatment and prevention of post-traumatic stress disorder (PTSD) at Biomed Israel 2022, the premier international Life Science and […]

Madrigal Mental Care Develops Psychedelic Drug Treatment for Post-Traumatic Stress Disorder Read More »

University of Wyoming, CaaMTech Team Up to Study Psychedelics as Treatments for Addiction

The University of Wyoming’s School of Pharmacy and CaaMTech, a Washington state-based company that engineers psychedelic drugs, recently formed a collaboration in which UW researchers will evaluate CaaMTech’s proprietary compounds in addiction models as well as aim to demonstrate their anti-addictive properties. Ana Clara Bobadilla, an assistant professor in the UW School of Pharmacy, will lead

University of Wyoming, CaaMTech Team Up to Study Psychedelics as Treatments for Addiction Read More »

Scroll to Top